Month: October 2023

BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB-6

BeiGene Announces Late-Breaking Data at ESMO Showing Tislelizumab plus Chemotherapy Significantly Improved Overall Survival at Final Analysis in First-Line Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB-4

BeiGene Announces the Phase 3 RATIONALE 315 Trial Met Primary Endpoints of Major Pathological Response Rate and Event-Free Survival for Tislelizumab Plus Chemotherapy in Patients with Resectable Non-Small Cell Lung Cancer (NSCLC)

news_6

WorkJam Expands Partnership with Blue Yonder to Fully Orchestrate Frontline Workforces with Task Management and Communications Tools

MONTREAL--(BUSINESS WIRE)--WorkJam, the world’s leading digital frontline workplace, announced today that it has expanded its long-term partnership with Blue Yonder,...